Company profile

AliveCor, Inc.

AliveCor, Inc. has 6 AI-enabled medical devices on the FDA list. The first decision was on March 11, 2019 and the most recent on January 9, 2026 (Corvair Monza). Its most common review panel is Cardiovascular (6 devices).

6AI devices

2019First decision

2026Latest decision

1Specialties

Per year

20192020202220242026

AliveCor, Inc. AI devices per year: 2019 1, 2020 1, 2022 1, 2024 2, 2026 1

By specialty

Cardiovascular6

Related guides

Top cardiovascular devices

Timeline

January 9, 2026 · 510(k) K252589Corvair Monza · Cardiovascular · MHX
June 7, 2024 · 510(k) K232035Impala · Cardiovascular · DPS
June 7, 2024 · 510(k) K231010Corvair · Cardiovascular · MHX
April 26, 2022 · 510(k) K212662AliveCor QT Service · Cardiovascular · DQK
November 12, 2020 · 510(k) K201985KardiaAI · Cardiovascular · DQK
March 11, 2019 · 510(k) K181823KardiaAI · Cardiovascular · DQK